About this Medicine article

DOP73 Efficacy and safety of escalation to tofacitinib 10 mg BID for patients with UC following loss of response on 5 mg BID maintenance therapy: Results from OCTAVE open-label, long-term extension study by Sands, B E; Moss, A C; Armuzzi, A; Marshall, J K; Lindsay, J O; Sandborn, W J; Danese, S; Zeroncio, M; Modesto, I; Salese, L; Lawendy, N; Zhang, H; Su, C is a Medicine article available to read on EtoBox.

Author

Sands, B E; Moss, A C; Armuzzi, A; Marshall, J K; Lindsay, J O; Sandborn, W J; Danese, S; Zeroncio, M; Modesto, I; Salese, L; Lawendy, N; Zhang, H; Su, C

Publisher

Oxford University Press; Oxford University Press (OUP) (ISSN 1873-9946)

Published

2020

Field

Medicine (Health Sciences)